Ignite Creation Date:
2025-12-24 @ 4:12 PM
Ignite Modification Date:
2026-02-02 @ 5:18 PM
Study NCT ID:
NCT00281866
Status:
COMPLETED
Last Update Posted:
2016-10-12
First Post:
2006-01-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Erlotinib in Treating Patients With Metastatic and/or Recurrent Head and Neck Cancer
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Head and Neck Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | stage IV squamous cell carcinoma of the hypopharynx | View |
| None | stage IV squamous cell carcinoma of the larynx | View |
| None | stage IV squamous cell carcinoma of the lip and oral … | View |
| None | stage IV squamous cell carcinoma of the nasopharynx | View |
| None | stage IV squamous cell carcinoma of the oropharynx | View |
| None | stage IV squamous cell carcinoma of the paranasal sinus and … | View |
| None | recurrent squamous cell carcinoma of the hypopharynx | View |
| None | recurrent squamous cell carcinoma of the larynx | View |
| None | recurrent squamous cell carcinoma of the lip and oral cavity | View |
| None | recurrent squamous cell carcinoma of the nasopharynx | View |
| None | recurrent squamous cell carcinoma of the oropharynx | View |
| None | recurrent squamous cell carcinoma of the paranasal sinus and nasal … | View |
| None | recurrent metastatic squamous neck cancer with occult primary | View |
| None | metastatic squamous neck cancer with occult primary squamous cell carcinoma | View |